Ikarian Capital, LLC - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 51 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q1 2022$110,000
-43.6%
155,606
+5.0%
0.01%
-51.7%
Q4 2021$195,000
-42.8%
148,1310.0%0.03%
+20.8%
Q3 2021$341,000
-48.3%
148,131
-1.2%
0.02%
-54.7%
Q2 2021$659,000
-63.7%
150,000
-40.0%
0.05%
-13.1%
Q1 2021$1,815,000250,0000.06%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q2 2022
NameSharesValueWeighting ↓
CHI Advisors LLC 5,307,751$3,101,0001.18%
TANG CAPITAL MANAGEMENT LLC 2,000,000$1,168,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$4,060,0000.08%
Artal Group S.A. 1,803,858$1,054,0000.06%
GSA CAPITAL PARTNERS LLP 616,402$360,0000.05%
RA Capital Management 3,040,885$1,776,0000.05%
Forefront Analytics, LLC 92,641$58,0000.03%
Temasek Holdings (Private) Ltd 4,319,049$2,523,1880.01%
FEDERATED HERMES, INC. 8,309,859$4,853,0000.01%
Cormorant Asset Management, LP 256,649$150,0000.01%
View complete list of ORCHARD THERAPEUTICS PLC shareholders